These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 4023756)

  • 1. Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising.
    DiStefano MJ; Markell JM; Doherty CC; Alexander GC; Anderson GF
    JAMA; 2023 Feb; 329(5):386-392. PubMed ID: 36749334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misleading advertising for antidepressants in Sweden: a failure of pharmaceutical industry self-regulation.
    Zetterqvist AV; Mulinari S
    PLoS One; 2013; 8(5):e62609. PubMed ID: 23650519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling the excesses of pharmaceutical marketing and promotion.
    Gupta R; Ramachandran R; Ross JS
    BMJ; 2024 May; 385():e076797. PubMed ID: 38772671
    [No Abstract]   [Full Text] [Related]  

  • 4. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
    Spurling GK; Mansfield PR; Montgomery BD; Lexchin J; Doust J; Othman N; Vitry AI
    PLoS Med; 2010 Oct; 7(10):e1000352. PubMed ID: 20976098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998.
    Ma J; Stafford RS; Cockburn IM; Finkelstein SN
    Clin Ther; 2003 May; 25(5):1503-17. PubMed ID: 12867225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic entry, reformulations and promotion of SSRIs in the US.
    Huskamp HA; Donohue JM; Koss C; Berndt ER; Frank RG
    Pharmacoeconomics; 2008; 26(7):603-16. PubMed ID: 18563951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Payments, promotion, and the purple pill.
    Ridley DB
    Health Econ; 2015 Jan; 24(1):86-103. PubMed ID: 25491652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of prescription drugs to consumers.
    Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
    N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of promotion on pharmaceutical demand.
    Mackowiak JI; Gagnon JP
    Soc Sci Med; 1985; 20(11):1191-7. PubMed ID: 4023756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of marketing in pharmaceutical research and development.
    Calfee JE
    Pharmacoeconomics; 2002; 20 Suppl 3():77-85. PubMed ID: 12457428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical industry marketing: understanding its impact on women's health.
    Sufrin CB; Ross JS
    Obstet Gynecol Surv; 2008 Sep; 63(9):585-96. PubMed ID: 18713478
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.